Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.

International journal of oncology

Volumn 25, Issue 6, 2004, Pages 1801-1807

  Lu, Xiaohua ^a   Hsieh, Tze Chen ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; EQUIGUARD; HERBACEOUS AGENT; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; SECRETION;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CYTOCHROMES C; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 16644390312     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.25.6.1801     Document Type: Article

References (0)